Literature DB >> 16770734

Interaction of prion protein with small highly structured RNAs: detection and characterization of PrP-oligomers.

Sara Vasan1, Phyllus Y Mong, Abraham Grossman.   

Abstract

Conformational modification of normal prion protein (PrP(c)) to protease-resistant, beta-sheet rich, aggregates (PrP(sc)) is commonly accepted cause for prion diseases. On the other hand, several studies in recent years implicate soluble, protease-sensitive, oligomers of PrP(c) in neuronal damage. Previously, our group has shown that small, highly structured RNAs (shsRNAs), in conjunction with a serum factor, facilitated the conversion of hrPrP to a protease resistant, high molecular weight isoform. In the current study we demonstrate that shsRNAs, in the absence of the serum factor, generate soluble, protease-sensitive, and potentially toxic oligomers of ovrPrP. We have isolated a 500 kD oligomer by size exclusion chromatography of the reaction mixture and identified the accessible epitopes. The soluble PrP-oligomers were present in enhanced amounts in scrapie infected sheep brain and treating extracts of normal sheep brain with shsRNA resulted in oligomerization of endogenous PrP. Isolation, characterization of PrP-oligomers and their possible implication in prion diseases is discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16770734     DOI: 10.1007/s11064-006-9063-5

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  52 in total

1.  Structural studies of soluble oligomers of the Alzheimer beta-amyloid peptide.

Authors:  T H Huang; D S Yang; N P Plaskos; S Go; C M Yip; P E Fraser; A Chakrabartty
Journal:  J Mol Biol       Date:  2000-03-17       Impact factor: 5.469

2.  Aggregation and fibrillization of the recombinant human prion protein huPrP90-231.

Authors:  W Swietnicki; M Morillas; S G Chen; P Gambetti; W K Surewicz
Journal:  Biochemistry       Date:  2000-01-18       Impact factor: 3.162

3.  Autocatalytic conversion of recombinant prion proteins displays a species barrier.

Authors:  Ilia V Baskakov
Journal:  J Biol Chem       Date:  2003-12-10       Impact factor: 5.157

4.  The peculiar nature of unfolding of the human prion protein.

Authors:  Ilia V Baskakov; Giuseppe Legname; Zygmunt Gryczynski; Stanley B Prusiner
Journal:  Protein Sci       Date:  2004-02-06       Impact factor: 6.725

Review 5.  Alzheimer's disease: the amyloid cascade hypothesis.

Authors:  J A Hardy; G A Higgins
Journal:  Science       Date:  1992-04-10       Impact factor: 47.728

6.  Cellular prion protein status in sheep: tissue-specific biochemical signatures.

Authors:  Mohammed Moudjou; Yveline Frobert; Jacques Grassi; Claude La Bonnardière
Journal:  J Gen Virol       Date:  2001-08       Impact factor: 3.891

7.  Oligomerization of beta-amyloid of the Alzheimer's and the Dutch-cerebral-haemorrhage types.

Authors:  A K Sian; E R Frears; O M El-Agnaf; B P Patel; M F Manca; G Siligardi; R Hussain; B M Austen
Journal:  Biochem J       Date:  2000-07-01       Impact factor: 3.857

Review 8.  Prion diseases of humans and animals: their causes and molecular basis.

Authors:  J Collinge
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

Review 9.  Cellular prion protein neuroprotective function: implications in prion diseases.

Authors:  Xavier Roucou; Andréa C LeBlanc
Journal:  J Mol Med (Berl)       Date:  2004-11-10       Impact factor: 4.599

10.  Formation of critical oligomers is a key event during conformational transition of recombinant syrian hamster prion protein.

Authors:  Fabian Sokolowski; Andreas Johannes Modler; Ralf Masuch; Dietrich Zirwer; Michael Baier; Gudrun Lutsch; David Alan Moss; Klaus Gast; Dieter Naumann
Journal:  J Biol Chem       Date:  2003-08-12       Impact factor: 5.157

View more
  5 in total

1.  Selective incorporation of polyanionic molecules into hamster prions.

Authors:  James C Geoghegan; Pablo A Valdes; Nicholas R Orem; Nathan R Deleault; R Anthony Williamson; Brent T Harris; Surachai Supattapone
Journal:  J Biol Chem       Date:  2007-10-16       Impact factor: 5.157

2.  Non-coding RNA as a trigger of neuropathologic disorder phenotypes in transgenic Drosophila.

Authors:  Elena Savvateeva-Popova; Andrej Popov; Abraham Grossman; Ekaterina Nikitina; Anna Medvedeva; Dmitry Molotkov; Nicholas Kamyshev; Konstantin Pyatkov; Olga Zatsepina; Natalya Schostak; Elena Zelentsova; Galina Pavlova; Dmitry Panteleev; Peter Riederer; Michail Evgen'ev
Journal:  J Neural Transm (Vienna)       Date:  2008-09-09       Impact factor: 3.575

3.  DNA Facilitates Oligomerization and Prevents Aggregation via DNA Networks.

Authors:  Theodore J Litberg; Brianne Docter; Michael P Hughes; Jennifer Bourne; Scott Horowitz
Journal:  Biophys J       Date:  2019-11-23       Impact factor: 4.033

4.  Pathogenic chaperone-like RNA induces congophilic aggregates and facilitates neurodegeneration in Drosophila.

Authors:  Elena Savvateeva-Popova; Andrei Popov; Abraham Grossman; Ekaterina Nikitina; Anna Medvedeva; Alexander Peresleni; Leonid Korochkin; James G Moe; Eliot Davidowitz; Konstantin Pyatkov; Elena Myasnyankina; Olga Zatsepina; Natalia Schostak; Elena Zelentsova; Michael Evgen'ev
Journal:  Cell Stress Chaperones       Date:  2007       Impact factor: 3.667

5.  In Vivo Validation of a Small Molecule Inhibitor of Tau Self-Association in htau Mice.

Authors:  Eliot J Davidowitz; Pavan K Krishnamurthy; Patricia Lopez; Heidy Jimenez; Leslie Adrien; Peter Davies; James G Moe
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.